Global HLA Typing Transplant Market 2017-2021 - Product Image

Global HLA Typing Transplant Market 2017-2021

  • ID: 4211572
  • Report
  • Region: Global
  • 70 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Biofortuna
  • Cellular Technology
  • HistoGenetics
  • Immucor
  • Linkage Biosciences
  • STRATEC Biomedical
  • MORE
Human leukocyte antigen (HLA) is located in the chromosome 6, which is present in almost all nucleated cells. The HLA system includes a complex array of genes, which controls the immune response through recognition of self and non-self antigens, which can lead to graft rejection. HLA typing, also known as tissue typing, is required majorly to examine graft rejection due to organ, tissue, blood cell, and bone marrow transplantation. Through this testing, bone marrow and blood cell transplantation complications can be minimized, which can increase the survival rate of the organ recipient.

The analysts forecast the global HLA typing transplant market to grow at a CAGR of 9.20% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global HLA typing transplant market for 2017-2021. To calculate the market size, the report considers revenue generated by the sales of products such as systems, assays, and accessories.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global HLA Typing Transplant Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Immucor
- Illumina
- Thermo Fisher Scientific

Other prominent vendors
- Biofortuna
- Bio-Rad Laboratories
- Cellular Technology
- GenDx
- HistoGenetics
- InGen
- Linkage Biosciences
- Omixon
- Pacific Biosciences of California
- STRATEC Biomedical

Market drivers
- Growing incidence of organ failure
- For a full, detailed list, view the full report

Market challenges
- High cost of transplantation and unfavorable reimbursement policies
- For a full, detailed list, view the full report

Market trends
- New government initiatives for HLA typing
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Biofortuna
  • Cellular Technology
  • HistoGenetics
  • Immucor
  • Linkage Biosciences
  • STRATEC Biomedical
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Key market highlights
  • Overview of HLA
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by products
  • Global HLA typing transplant market by systems and software
  • Global HLA typing transplant market by reagents and accessories
PART 07: Market segmentation by technology

PART 08: Market segmentation by end-user
  • Hospitals and transplant centers
  • Donor registries and research laboratories
PART 09: Geographical segmentation
  • HLA typing transplant market in Americas
  • HLA typing transplant market in EMEA
  • HLA typing transplant market in APAC
PART 10: Decision framework

PART 11: Drivers and challenges
  • Market drivers
  • Impact of drivers on key customer segments
  • Market challenges
  • Impact of challenges on key customer segments
PART 12: Market trends
  • Evolving sales strategies of vendors with changing market dynamics
  • New government initiatives for HLA typing
  • New product approvals and launches
PART 13: Vendor landscape
  • Competitive landscape
PART 14: Key vendor analysis
  • Immucor
  • Illumina
  • Thermo Fisher Scientific
  • Key companies to watch out for
  • Other prominent vendors
PART 15: Appendix
  • List of abbreviations
List of Exhibits

Exhibit 01: Types of HLA and their LOCi
Exhibit 02: NGS and traditional sequencing
Exhibit 03: Kidney and liver transplantation: Number of deceased and living donors 2014
Exhibit 04: Global HLA typing transplant market 2016-2021 ($ millions)
Exhibit 05: Strategies for new entrants and present companies in market
Exhibit 06: Five forces analysis
Exhibit 07: Market overview: Systems
Exhibit 08: Market overview: Software
Exhibit 09: Global HLA typing transplant market by systems and software 2016-2021 ($ millions)
Exhibit 10: Market impact analysis and product dynamics of HLA typing systems and software
Exhibit 11: Market overview: Reagents and accessories
Exhibit 12: Global HLA typing transplant market for reagents and accessories 2016-2021 ($ millions)
Exhibit 13: Market impact analysis and product dynamics of HLA typing reagents and accessories
Exhibit 14: Global HLA typing transplant market by technology 2016
Exhibit 15: Global HLA typing transplant market by end-user 2016
Exhibit 16: Global HLA typing transplant market by geography in 2016 and 2021 ($ millions)
Exhibit 17: Market overview: HLA typing transplant market in Americas
Exhibit 18: Survival probability of Diamond-Blackfan anemia patients in US 2008-2012
Exhibit 19: HLA typing transplant market in Americas 2016-2021 ($ millions)
Exhibit 20: HLA typing transplant market in Americas: Market analysis in various countries
Exhibit 21: Types of organ transplantation in US (2015)
Exhibit 22: Market overview: HLA typing transplant market in US
Exhibit 23: Market overview: HLA typing transplant market in EMEA
Exhibit 24: Profiles of key transplant centers in Europe
Exhibit 25: HLA typing transplant market in EMEA 2016-2021 ($ millions)
Exhibit 26: HLA typing transplant market in EMEA: Market analysis in various countries
Exhibit 27: Market overview: HLA typing transplant market in UK
Exhibit 28: Market overview: HLA typing transplant market in APAC
Exhibit 29: HLA typing transplant market in APAC 2016-2021 ($ millions)
Exhibit 30: HLA typing transplant in APAC: Market analysis in various countries
Exhibit 31: Market overview: HLA typing transplant market in Australia
Exhibit 32: Market impact analysis: Technology advancements
Exhibit 33: Number of hospitals merged and acquired between 2010 and 2015 in US
Exhibit 34: Impact of drivers
Exhibit 35: Average cost of transplantation procedure
Exhibit 36: Average cost of sequencers of different companies
Exhibit 37: Legal and ethical issues in countries for solid organ transplantation
Exhibit 38: Impact of challenges
Exhibit 39: Strategies of vendors in global HLA typing transplant market
Exhibit 40: Government programs and its market impact in few countries
Exhibit 41: Competitive structure analysis of global HLA typing transplant market 2016
Exhibit 42: Competitive landscape of global HLA typing transplant market 2016
Exhibit 43: Strategies for large and small companies in global HLA typing transplant market
Exhibit 44: Immucor: Strength assessment
Exhibit 45: Immucor: Strategy assessment
Exhibit 46: Immucor: Opportunity assessment
Exhibit 47: Illumina: Strength assessment
Exhibit 48: Illumina: Strategy assessment
Exhibit 49: Illumina: Opportunity assessment
Exhibit 50: Thermo Fisher Scientific: Strength assessment
Exhibit 51: Thermo Fisher Scientific: Strategy assessment
Exhibit 52: Thermo Fisher Scientific: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Biofortuna
  • Cellular Technology
  • HistoGenetics
  • Immucor
  • Linkage Biosciences
  • STRATEC Biomedical
  • MORE
New Report Released: - Global HLA Typing Transplant Market 2017-2021

The author of the report recognizes the following companies as the key players in the global HLA typing transplant market: Immucor, Illumina and Thermo Fisher Scientific.

Other Prominent Vendors in the market are: Biofortuna, Bio-Rad Laboratories, Cellular Technology, GenDx, HistoGenetics, InGen, Linkage Biosciences, Omixon, Pacific Biosciences of California and STRATEC Biomedical.

Commenting on the report, an analyst from the research team said: “One trend in the market is new government initiatives for HLA typing. The growing concerns about hepatitis and HIV are leading the government to develop few standards and strategies to reduce the number of communicable diseases through transplantation. Quality measurement in government-introduced programs lead to increased adoption of bone marrow and umbilical cord transplantation.”

According to the report, one driver in the market is growing incidence of organ failure. The demand for tissue and organs such as bone marrow, heart, liver, kidney, and lungs is very high worldwide. The increasing rate of alcohol consumption, unhealthy lifestyles and food habits, and drug intake are the leading causes of organ failure. In addition, the rise in older adult population results in increased demand for organs for transplantation. According to a combined study conducted by the Department of Internal Medicine, Division of Hepatology, Loyola University Medical Center; Department of Preventive Health Sciences, Stritch School of Medicine, Loyola University Chicago; and Division of Gastroenterology and Hepatology, University of Michigan Health System, in 2015, liver cirrhosis is one of the major factors of death in the US.

Further, the report states that one challenge in the market is ethical challenges in organ transplantation. The unavailability of organs is one of the leading challenges in the market. This leads many companies and universities to research and focus on developing artificial organs. However, owing to the disparity on ethical and legal rights, the adoption and donation of organs have been affected negatively. For instance, the detection of a genetic defect is conducted through preimplantation genetic screening (PGS) through in-vitro fertilization. In such cases, physicians use allogenic haematopoietic stem cell transplantation for children who are suffering from severe leukemia, beta-thalassaemia, and Diamond-Blackfan anaemia.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Immucor
  • Illumina
  • Thermo Fisher Scientific
  • Biofortuna
  • Bio-Rad Laboratories
  • Cellular Technology
  • GenDx
  • HistoGenetics
  • InGen
  • Linkage Biosciences
  • Omixon
  • Pacific Biosciences of California
  • STRATEC Biomedical
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll